Sancy Leachman, M.D., Ph.D.
- Dermatology, Cancer
- Special Interests:
- General Dermatology, Melanoma, Skin Cancers, Genetic Skin Disorders
- Accepting Patients:
Academic and Clinical Positions
Professor and Chair, Department of Dermatology
Director, Melanoma Research Program, Knight Cancer Institute
Sancy Leachman, M.D., Ph.D., is a physician-scientist who chairs the Department of Dermatology and is the director of the Melanoma Research Program at the Knight Cancer Institute. She is a dermatologist using basic science research and state-of-the-art technology to combat skin cancer.
Her clinical interests include skin cancers, especially melanoma, pigmentary disorders that result from abnormalities of melanocytes such as vitiligo, and genetic disorders that involve the skin such as pachyonychia congenita, Cowden syndrome, and other cutaneous cancer syndromes.
In addition to seeing patients with pigmentary disorders, she sees general dermatology patients at the Center for Health & Healing and the Lake Oswego dermatology clinics.
Prior to joining OHSU in 2013, Dr. Leachman was at the University of Utah, where she was director of the Melanoma and Cutaneous Oncology Program in the Huntsman Cancer Institute, a professor in the Department of Dermatology, and member of the Imaging, Diagnostics, and Therapeutics Program and the Cancer Control and Population Sciences Program.
Leachman was a key figure in developing the Melanoma and Cutaneous Oncology Program at Huntsman Cancer Institute. We are excited to have her talent in team building in Oregon to improve the care of patients in our community by bringing together researchers and physicians with an interest in melanoma and other skin cancers in order to bring knowledge and expertise from the laboratory into the clinical realm.
Leachman’s research examines the role of genetic predisposition and differential gene expression in the development of melanoma, with an emphasis on the familial melanoma syndrome. Through her investigations, she is seeking to develop agents that will serve as diagnostic tools, prognostic indicators, or targeted agents for the prevention of melanoma.
Leachman also worked on a DNA vaccination study to prevent and treat papillomavirus-induced squamous cell carcinoma at Yale University School of Medicine where she completed her residency training and research fellowship. Leachman was awarded the prestigious Doris Duke Clinical Scientist Development Award in 2000 and is currently an NIH R01- and Department of Defense-funded principle investigator.
When not working, Leachman spends time with her husband and two children in outdoor pursuits including hiking, skiing and backpacking and is looking forward to exploring the Pacific Northwest.
Learn more about the OHSU Department of Dermatology.
M.D., Ph.D., University of Texas Southwestern Medical School, Dallas, TX, USA, 1993
B.A., University of Texas at Austin Plan II, Austin, TX, USA, 1985
Yale-New Haven Hospital (Dermatology), New Haven, CT
Yale University School of Medicine (Cutaneous Oncology), New Haven, CT
American Board of Dermatology